scispace - formally typeset
V

Vuk Janjić

Researcher at Imperial College London

Publications -  10
Citations -  1593

Vuk Janjić is an academic researcher from Imperial College London. The author has contributed to research in topics: Network topology & Biological network. The author has an hindex of 9, co-authored 10 publications receiving 1300 citations.

Papers
More filters
Journal ArticleDOI

A global genetic interaction network maps a wiring diagram of cellular function

TL;DR: A global genetic interaction network highlights the functional organization of a cell and provides a resource for predicting gene and pathway function and how coherent sets of negative or positive genetic interactions connect protein complex and pathways to map a functional wiring diagram of the cell.
Journal ArticleDOI

Revealing the Hidden Language of Complex Networks

TL;DR: This work discovers that the interaction between a small number of roles, played by nodes in a network, can characterize a network's structure and also provide a clear real-world interpretation, and develops a framework for analysing and comparing networks, which outperforms all existing ones.
Journal ArticleDOI

Discovering disease-disease associations by fusing systems-level molecular data

TL;DR: This work finds 14 disease-disease associations currently not present in Disease Ontology and provides evidence for their relationships through comorbidity data and literature curation and finds they are the most important predictor of a link between diseases.
Journal ArticleDOI

Biological function through network topology: a survey of the human diseasome

TL;DR: This work surveys current network analysis methods that aim to give insight into human disease, aiming to untangle the complexity of cellular network organization.
Journal ArticleDOI

Network topology reveals key cardiovascular disease genes.

TL;DR: This work proposes a methodology that examines the PPI network wiring around genes involved in CVDs to identify a subset of CVD-related genes that are statistically significantly enriched in drug targets and “driver genes,” and shows that these genes are functionally similar to currently known CVD drug targets, which confirms a potential utility of the methodology towards improving therapy forCVDs.